Solid Biosciences Stock (NASDAQ: SLDB) stock price, news, charts, stock research, profile.
Open | $9.70 |
Close | $9.56 |
Volume / Avg. | 297.04K / 476.64K |
Day Range | $9.39 - $10.07 |
52 Wk Range | 1.81 - 15.05 |
Market Cap | $368.97M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | 8.59% |
Days to Cover | 4.42 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Solid Biosciences (NASDAQ:SLDB) through any online brokerage.
Other companies in Solid Biosciences’s space includes: Precigen (NASDAQ:PGEN), Inozyme Pharma (NASDAQ:INZY), Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO) and PepGen (NASDAQ:PEPG).
Solid Biosciences has a consensus price target of $15.00.
The stock price for Solid Biosciences (NASDAQ: SLDB) is $9.56 last updated August 23, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Solid Biosciences.
Solid Biosciences’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Solid Biosciences.
Solid Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.